Morning Market Losers By: Benzinga via Benzinga January 07, 2015 at 09:50 AM EST KaloBios Pharmaceuticals, Inc. (NASDAQ: KBIO) shares dipped 66.67% to $0.61 after the company reported top-line data from phase 2 study ... Read More >> Related Stocks: Karyopharm Therapeut Liqtech International Inc Medicines Company Micron Technology RPM International Inc